| Api Name | Category | Regulatory Status | India Registration | Formulation |
|---|---|---|---|---|
| Abiraterone Acetate | Oncology | USDMF, EDMF & Canada DMF | Available | Oral |
| Ademetionine 1,4-Butanedisulfonate | Nutritional Supplement | WC | Available | Oral |
| Allylestrenol | Hormonal Agent | - | - | Oral |
| Cardiose | Nutritional Supplement | - | - | Oral |
| Dexamethasone Base | Anti-inflammatory Agent | USFDA, Canada FDA | Available | Oral |
| Dienogest | Hormonal Agent | - | - | Oral |
| Diosmin | Vasoprotective Agent | EUGMP | Available | Oral |
| Doxycycline Hyclate | Tetracycline Antibiotic | USDMF, CEP | - | Oral |
| Doxycycline Monohydrate | Tetracycline Antibiotic | USDMF, CEP | - | Oral |
| Dydrogesterone | Hormonal Agent | USDMF, EDMF | Available | Oral |
| Enzalutamide | Antineoplastic Agent | USDMF & EDMF | - | Oral |
| Eplerenone | Cardiovascular Drug | USDMF, CEP, EDMF, CDMF | Available | Oral |
| Glutathione | Nutritional Supplement | JDMF | Available | Oral |
| Hesperidin | Vasoprotective Agent | - | Available | Oral |
| Medroxyprogesterone Acetate | Hormonal Agent | USDMF | Available | Oral |
| Megesterol Acetate | Hormonal Agent | - | - | Oral |
| Methylcobalamin | Vitamin Supplement | EUGMP, USDMF | Under Registration | Oral |
| Mifepristone | Antineoplastic Agent | - | Available | Oral |
| Minocycline Hydrochloride | Tetracycline Antibiotic | USDMF, CEP, JDMF | Available | Oral |
| MPFF (Diosmin/Hesperidin) 90:10 | Vasoprotective Agent | EUGMP | Under Registration | Oral |
| Nandrolone Decanoate | Hormonal Agent | - | - | Oral |
| Neomycin Sulfate (Human) | Aminoglycoside | USFDA, Canada FDA | - | Oral |
| Nitrofurantoin Macrocrystals | UTI Treatment | USDMF Submission Plan Q4 2022 | - | Oral |
| Norethisterone Acetate | Hormonal Agent | USDMF Filed | Available | Oral |
| Norethisterone Base | Hormonal Agent | USDMF Filed | - | Oral |
| Prednisolone Base | Anti-inflammatory Agent | - | Available | Oral |
| Progesterone | Hormonal Agent | USDMF, CEP, JDMF | Available | Oral |
| Semaglutide | GLP-1 Analogue | USDMF | - | Oral |
Name |
Contact Number |
|
|---|---|---|
| Dr Sanjay Loomba | +91 8121007791 | sanjay@rifapharma.com |
| Ms Nidhi Sampat | +91 9987776776 | nidhi.sampat@rifapharma.com |
Together, we ensure every product meets the highest global pharmaceutical standards.
Our commitment to quality, compliance, and consistency drives every partnership we build, delivering trusted solutions to markets worldwide.
Mumbai
Hyderabad
China
Vapi, Gujarat(Warehouse)
+91 9619494942
+91 9702958555
+91 9987776776
Copyright 2022 Rifa Pharma | Designed and Developed By Enliten IT
Connect with our Medical Devices Specialist for product guidance, technical support, and partnership inquiries.
|
Name |
Contact Number |
|
|---|---|---|
| Disha Desai | +91 96194 94942 | disha.desai@rifapharma.com |
Ms. Desai has masterfully elevated the valuation of the Packaging and Medical Devices division, breaking barriers and unlocking new opportunities. She is an invaluable force with over 10+ years of expertise and a portfolio of 30+ customer companies. Her relentless hustle, strategic vision, and unwavering determination not only seize opportunities but create them, driving unprecedented growth and success.
Ms. Ujwala is a razor-sharp professional with an unwavering focus on delivering results. With deep expertise in the veterinary premix market, she ensures every promise and goal is achieved. Her tenacity, proficiency with active ingredients, and strategic foresight set her apart. Leading sales and new developments at Rifa Pharma, she drives innovation, sustainability, and impactful growth, making her a trusted advisor and partner in success.
Our CEO and partner - Dr. Sanjay Loomba, a trauma surgeon and visionary leader, brings over 18 years of expertise in healthcare and the pharmaceutical industry. He has been instrumental in establishing advanced manufacturing facilities and optimising procurement for global markets. Currently, at Rifa Pharma, he focuses on driving innovation, enhancing operational excellence, promoting sustainability, and delivering patient-centric solutions that address the evolving needs of the healthcare sector.
Neha is a dynamic and accomplished leader at Rifa Pharma, bringing over 25 years of expertise in the pharmaceutical industry, with a strong focus on operations. She is highly proficient in business development and regulatory affairs, successfully securing global approvals and driving impactful market expansion. As the Vice Chairperson of the IDMA Bulk Drug Committee, she plays a pivotal role in enhancing industry influence. Her comprehensive expertise extends across corporate governance, ESG strategy, and stakeholder engagement, ensuring sustainable growth and unwavering compliance excellence..
Anant Thakore embodies resilience, vision, and leadership.Stepping in during a critical phase, he revolutionized the company,driving it to a remarkable $60 million indenting enterprise.A true pioneer in India’s pharmaceutical landscape,he played a crucial role in advancing anti-tuberculosis and antibiotic manufacturing. His groundbreaking achievements include becoming the first indigenous manufacturer of corticosteroids,solidifying his legacy as a transformative force in the industry.
